Metabolic syndrome and robustness tradeoffs

Diabetes

Volumn 53, Issue SUPPL. 3, 2004, Pages

  Kitano, Hiroaki ^a,b,c   Oda, Kanae ^d   Kimura, Tomomi ^b,d   Matsuoka, Yukiko ^e   Csete, Marie ^f   Doyle, John ^g   Muramatsu, Masaaki ^d  

^a SONY COMPUTER SCIENCE LABORATORIES INC   (Japan)

^b Systems Biology Institute   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f EMORY UNIVERSITY   (United States)

^g CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; METABOLIC DISORDER; METABOLIC SYNDROME X; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RESEARCH; SYSTEMIC DISEASE;

DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X;

EID: 7644241654     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.suppl_3.S6     Document Type: Conference Paper

References (70)

1. Kitano H: Computational systems biology. Nature 420:206-210, 2002
2. Kitano H: Systems biology: a brief overview. Science 295:1662-1664, 2002
3. Alon U, Surette MG, Barkai N, Leibler S: Robustness in bacterial chemotaxis. Nature 397:168-171, 1999
4. Barkai N, Leibler S: Robustness in simple biochemical networks. Nature 387:913-917, 1997
5. Eldar A, Dorfman R, Weiss D, Ashe H, Shilo BZ, Barkai N: Robustness of the BMP morphogen gradient in Drosophila embryonic patterning. Nature 419:304-308, 2002
6. Little JW, Shepley DP, Wert DW: Robustness of a gene regulatory circuit. EMBO J 18:4299-4307, 1999
7. McAdams HH, Arkin A: It's a noisy business! Genetic regulation at the nanomolar scale. Trends Genet 15:65-69, 1999
8. Meir E, von Dassow G, Munro E, Odell GM: Robustness, flexibility, and the role of lateral inhibition in the neurogenic network. Curr Biol 12:778-786, 2002
9. Morohashi M, Winn AE, Borisuk MT, Bolouri H, Doyle J, Kitano H: Robustness as a measure of plausibility in models of biochemical networks. J Theor Biol 216:19-30, 2002
10. Ueda HR, Hagiwara M, Kitano H: Robust oscillations within the interlocked feedback model of Drosophila circadian rhythm. J Theor Biol 210:401-406, 2001
11. von Dassow G, Meir E, Munro EM, Odell GM: The segment polarity network is a robust developmental module. Nature 406:188-192, 2000
12. Yi TM, Huang Y, Simon MI, Doyle J: Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci USA 97:4649-4653, 2000
13. Carlson JM, Doyle J: Highly optimized tolerance: a mechanism for power laws in designed systems. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 60:1412-1427, 1999
14. Carlson JM, Doyle J: Complexity and robustness. Proc Natl Acad Sci USA 99 (Suppl. 1):2538-2545, 2002
15. Csete ME, Doyle JC: Reverse engineering of biological complexity. Science 295:1664-1669, 2002
16. Kitano H: Cancer robustness: tumour tactics. Nature 426:125, 2003
17. Kitano H: Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 4:227-235, 2004
18. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
19. Porte D, Sherwin R, Baron A: Diabetes Mellitus. New York, McGraw-Hill, 2003
20. Zimmet PZ, Alberti KG: The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet 350 (Suppl. 1):S1-S4, 1997
21. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782-787, 2001
22. Newsholme P, Curi R, Gordon S, Newsholme EA: Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J 239:121-125, 1986
23. Liu YJ, Saini A, Cohen DJ, Ooi BS: Modulation of macrophage proliferation by hyperglycemia. Mol Cell Endocrinol 114:187-192, 1995
24. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395:763-770, 1998
25. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
26. Inui A: Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2:551-560, 2001
27. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806, 2001
28. Rui L, Yuan M, Frantz D, Shoelson S, White MF: SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394-42398, 2002
29. Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, Hotamisligil GS, Van Obberghen E: SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem 276:47944-47949, 2001
30. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E: SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 275:15985-15991, 2000
31. Warne JP: Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J Endocrinol 177:351-355, 2003
32. Bullo-Bonet M, Garcia-Lorda P, Lopez-Soriano FJ, Argiles JM, Salas-Salvado J: Tumour necrosis factor, a key role in obesity? FEBS Lett 451:215-219, 1999
33. Argiles JM, Lopez-Soriano J, Busquets S, Lopez-Soriano FJ: Journey from cachexia to obesity by TNF. FASEB J 11:743-751, 1997
34. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
35. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
36. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858, 1994
37. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-614, 1997
38. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
39. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099, 2001
40. Fernandez-Real JM, Ricart W: Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42:1367-1374, 1999
41. Newsholme P, Costa Rosa LF, Newsholme EA, Curi R: The importance of fuel metabolism to macrophage function. Cell Biochem Fund 14:1-10, 1996
42. Healy DA, Watson RW, Newsholme P: Glucose, but not glutamine, protects against spontaneous and anti-Fas antibody-induced apoptosis in human neutrophils. Clin Sci (Lond) 103:179-189, 2002
43. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830, 2003
44. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
45. Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788, 2003
46. Kuniyasu A, Ohgami N, Hayashi S, Miyazaki A, Horiuchi S, Nakayama H: CD36-mediated endocytic uptake of advanced glycation end products (AGE) In mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett 537:85-90, 2003
47. Hotamisligil GS: Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 24 (Suppl. 4):S23-S27, 2000
48. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996
49. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
50. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF: Tumor necrosis factor-alpha suppresses adipocyte-spedfic genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 51:1319-1336, 2002
51. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737, 2002
52. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540, 2002
53. Lee SC, Pu YB, Thomas GN, Lee ZS, Tomlinson B, Cockram CS, Critchley JA, Chan JC: Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 49:1021-1024, 2000
54. Libby P: Inflammation in atherosclerosis. Nature 420:868-874, 2002
55. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133, 2001
56. Moller DE: New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821-827, 2001
57. Moller DE, Greene DA: Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes. Adv Protein Chem 56:181-212, 2001
58. Willson TM, Brown PJ, Sternbach DD, Henke BR: The PPARs: from orphan receptors to drug discovery. J Med Chem 43:527-550, 2000
59. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Mild H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T: The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 276:41245-41254, 2001
60. Fonseca V: Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med 115 (Suppl. 8A):42S-48S, 2003
61. Abrahamson MJ: Clinical use of thiazolidinediones: recommendations. Am J Med 115 (Suppl. 8A):116S-120S, 2003
62. Bondeson J, Maini RN: Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE). Int J Clin Pract 55:211-216, 2001
63. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
64. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, Cuellar AA, Dronov S, Gilles ED, Ginkel M, Gor V, Goryanin II, Hedley WJ, Hodgman TC, Hofmeyr JH, Hunter PJ, Juty NS, Kasberger JL, Kremling A, Kummer U, Le Novere N, Loew LM, Lucio D, Mendes P, Minch E, Mjolsness ED, Nakayama Y, Nelson MR, Nielsen PF, Sakurada T, Schaff JC, Shapiro BE, Shimizu TS, Spence HD, Stelling J, Takahashi K, Tomita M, Wagner J, Wang J: The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19:524-531, 2003
65. Kitano H: A graphical notation for biochemical networks. Biosilico 1:169-176, 2003
66. Funahashi A, Kitano H: CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. Biosilico 1:159-162, 2003
67. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle J, Kitano H: The ERATO Systems Biology Workbench: enabling interaction and exchange between software tools for computational biology. Pac Symp Biocomput 450-461, 2002
68. Sauro HM, Hucka M, Finney A, Wellock C, Bolouri H, Doyle J, Kitano H: Next generation simulation tools: the Systems Biology Workbench and BioSPICE integration. Omics 7:355-372, 2003
69. Prajna S, Papachristodoulou A. Analysis of switched and hybrid systems: beyond piecewise quadratic methods. In Proceedings of American Control Conference. New York, IEEE, 2003, p. 2779-2784
70. Prajna S, Papachristodoulou A, Parrilo PA: Introducing SOSTOOLS: a general purpose sum of square programming solver. In Proceedings of IEEE Conference on Decision and Control. New York, IEEE, 2002, p. 741-746